Titan Pharmaceuticals Inc (TTNP) — Net Asset Quality Index
Titan Pharmaceuticals Inc (TTNP) has a Net Asset Quality Index of 91.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.05 Million minus total liabilities of $263.00K yields net assets of $2.79 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Titan Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Titan Pharmaceuticals Inc Net Asset Quality Index Over Time (1995–2024)
This chart shows how Titan Pharmaceuticals Inc's Net Asset Quality Index has evolved across 30 annual periods from 1995 to 2024. As of June 2025, the index stands at 91.4%, representing net assets of $2.79 Million against total assets of $3.05 Million USD. See how liquid is Titan Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Titan Pharmaceuticals Inc (1995–2024)
The table below presents the year-by-year Net Asset Quality Index for Titan Pharmaceuticals Inc from 1995 to 2024, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Titan Pharmaceuticals Inc worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.5% | $2.44 Million | $2.92 Million | $483.00K | ▲ +1.3 pp |
| 2023 | 82.1% | $6.64 Million | $8.09 Million | $1.44 Million | ▲ +48.6 pp |
| 2022 | 33.6% | $1.36 Million | $4.06 Million | $2.69 Million | ▼ -30.7 pp |
| 2021 | 64.3% | $5.14 Million | $7.99 Million | $2.86 Million | ▲ +20.6 pp |
| 2020 | 43.7% | $3.53 Million | $8.09 Million | $4.55 Million | ▲ +28.6 pp |
| 2019 | 15.0% | $1.43 Million | $9.52 Million | $8.09 Million | ▼ -33.4 pp |
| 2018 | 48.5% | $6.83 Million | $14.10 Million | $7.26 Million | ▲ +38.8 pp |
| 2017 | 9.6% | $857.00K | $8.90 Million | $8.05 Million | ▼ -61.0 pp |
| 2016 | 70.7% | $13.19 Million | $18.67 Million | $5.48 Million | ▲ +18.1 pp |
| 2015 | 52.6% | $6.99 Million | $13.29 Million | $6.30 Million | ▲ +11.3 pp |
| 2014 | 41.3% | $8.61 Million | $20.85 Million | $12.24 Million | ▲ +10.0 pp |
| 2013 | 31.3% | $5.76 Million | $18.42 Million | $12.66 Million | ▲ +124.4 pp |
| 2012 | -93.2% | $-23.13 Million | $24.83 Million | $47.95 Million | ▲ +103.4 pp |
| 2011 | -196.5% | $-20.08 Million | $10.22 Million | $30.30 Million | ▼ -69.1 pp |
| 2010 | -127.4% | $-6.05 Million | $4.75 Million | $10.80 Million | ▼ -121.8 pp |
| 2009 | -5.6% | $-207.00K | $3.73 Million | $3.93 Million | ▼ -37.1 pp |
| 2008 | 31.6% | $1.80 Million | $5.70 Million | $3.90 Million | ▼ -54.6 pp |
| 2007 | 86.2% | $26.59 Million | $30.84 Million | $4.26 Million | ▲ +8.8 pp |
| 2006 | 77.4% | $11.65 Million | $15.04 Million | $3.39 Million | ▼ -6.7 pp |
| 2005 | 84.1% | $16.60 Million | $19.74 Million | $3.14 Million | ▼ -6.4 pp |
| 2004 | 90.5% | $34.95 Million | $38.63 Million | $3.67 Million | ▼ -2.7 pp |
| 2003 | 93.2% | $45.67 Million | $49.01 Million | $3.34 Million | ▼ -1.6 pp |
| 2002 | 94.8% | $71.98 Million | $75.93 Million | $3.94 Million | ▲ +0.2 pp |
| 2001 | 94.6% | $101.37 Million | $107.13 Million | $5.76 Million | ▼ -3.3 pp |
| 2000 | 97.9% | $115.98 Million | $118.44 Million | $2.46 Million | ▲ +1.9 pp |
| 1999 | 96.0% | $45.50 Million | $47.40 Million | $1.90 Million | ▲ +9.1 pp |
| 1998 | 86.9% | $10.60 Million | $12.20 Million | $1.60 Million | ▲ +15.0 pp |
| 1997 | 71.9% | $18.40 Million | $25.60 Million | $7.20 Million | ▼ -5.0 pp |
| 1996 | 76.8% | $12.60 Million | $16.40 Million | $3.80 Million | ▲ +174.7 pp |
| 1995 | -97.9% | $-4.60 Million | $4.70 Million | $9.30 Million | — |